CROs vs. in‑house: who runs better trials in Europe?
The age‑old debate: hire a contract research organization (CRO) or keep it in‑house? In Europe, big pharma often mixes both. CROs like IQVIA and Parexel bring global reach and niche expertise — from rare disease recruitment to complex biomarker analysis. The Europe clinical trials market research study shows that pharmaceutical companies hold the largest end‑use share, but...
0 Reacties 0 aandelen 10 Views 0 voorbeeld